• Logo
  • SBMUJournals

Chronic myeloid leukemia as a stem cell-derived malignancy

Sadegh Babashah, Mostafa Rezaei-Tavirani, Mona Zamanian-Azodi, Najmaldin Saki




Chronic myeloid leukemia (CML) is a myeloproliferative disease of the hematopoietic stem cells, characterized by the presence of the Philadelphia (Ph) chromosome. Although imatinib inhibits the BCR-ABL kinase activity, clinical experiences confirm that imatinib may not target CML stem cells in vivo. The identification of signaling pathways responsible for the self-renewal properties of leukemic stem cells in CML will help in the discovery of novel therapeutic targets. Here we review signaling pathways including Wnt/β-catenin, Hedgehog, Alox5, and Foxo which play crucial roles in the maintenance of stem cell functions in CML. It is thought that inhibition of key genes that are part of self-renewal associated signaling pathways may provide an effective way to reduce aberrant stem cell renewal in CML.


cancer stem cells; chronic myeloid leukemia stem cells; signaling pathway; microRNA

DOI: https://doi.org/10.22037/jps.v3i2.3479


  • There are currently no refbacks.